TransCode Therapeutics Announces Agreement with Triton Funds for Sale of Series A Convertible Preferred Stock
BOSTON, April 03, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an…
Year: 2023
TransCode Therapeutics Announces Agreement with Triton Funds for Sale of Series A Convertible Preferred Stock
BOSTON, April 03, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an…
Eloxx Pharmaceuticals Reports Fourth Quarter 2022 Financial and Operating Results and Provides Business Update
Three patients now dosed in Phase 2 clinical study evaluating ELX-02 for the treatment of…
Eloxx Pharmaceuticals Reports Fourth Quarter 2022 Financial and Operating Results and Provides Business Update
Three patients now dosed in Phase 2 clinical study evaluating ELX-02 for the treatment of…
Vaccinex Reports 2022 Financial Results and Provides Corporate Update of Continued Progress in Neurology and Oncology Clinical Programs
Expect to complete patient enrollment in the randomized Phase 1/2a SIGNAL-AD Alzheimer’s study in April…
Vaccinex Reports 2022 Financial Results and Provides Corporate Update of Continued Progress in Neurology and Oncology Clinical Programs
Expect to complete patient enrollment in the randomized Phase 1/2a SIGNAL-AD Alzheimer’s study in April…
Windtree Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Key Business Updates
WARRINGTON, Pa., April 03, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology…
Windtree Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Key Business Updates
WARRINGTON, Pa., April 03, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology…
Sandoz receives approval by European Commission for Hyrimoz® (adalimumab) high-concentration formulation
Biosimilar Hyrimoz® (adalimumab) citrate-free high-concentration formulation (HCF) is now approved in the EU for use…
Sandoz receives approval by European Commission for Hyrimoz® (adalimumab) high-concentration formulation
Biosimilar Hyrimoz® (adalimumab) citrate-free high-concentration formulation (HCF) is now approved in the EU for use…
Startup Confirm, an Innovator in HR Tech, Accepted into SHRMLabs WorkplaceTech Accelerator Program
Program for HR startups-to-watch includes mentoring and a $160,000 equity investment from SHRM Confirm brings…
Startup Confirm, an Innovator in HR Tech, Accepted into SHRMLabs WorkplaceTech Accelerator Program
Program for HR startups-to-watch includes mentoring and a $160,000 equity investment from SHRM Confirm brings…
Trailbreaker Resources Receives Structural Report, Drill Recommendations for Atsutla Gold Project, Northwestern BC
Figure 1: Detailed geological map of the Swan mineralized zone. VANCOUVER, British Columbia, April 03,…
VYRE Network Announces the Appointment of Harris “P Gordy” Brown as President of VYRE Live
Harris Brown will lead Event Production, VYRE Live Concerts, and Live Stream PPV services beginning…
VYRE Network Announces the Appointment of Harris “P Gordy” Brown as President of VYRE Live
Harris Brown will lead Event Production, VYRE Live Concerts, and Live Stream PPV services beginning…
Plymouth Rock Announces Further Private Placement Financing and Director Resignation
Vancouver, British Columbia–(Newsfile Corp. – April 3, 2023) – Plymouth Rock Technologies Inc. (CSE: PRT)…
Plymouth Rock Announces Further Private Placement Financing and Director Resignation
Vancouver, British Columbia–(Newsfile Corp. – April 3, 2023) – Plymouth Rock Technologies Inc. (CSE: PRT)…
Unprecedented Support for Founders Distinguishes Staircase Ventures, New Fund by Janet Bannister
Fund offers first-of-its-kind growth and development program to enhance founders’ performance and business success. Toronto,…
Unprecedented Support for Founders Distinguishes Staircase Ventures, New Fund by Janet Bannister
Fund offers first-of-its-kind growth and development program to enhance founders’ performance and business success. Toronto,…
DGTL Holdings Inc. Reports on Grant of Options and DSUs
Toronto, Ontario–(Newsfile Corp. – April 3, 2023) – DGTL Holdings Inc. (TSXV: DGTL) (OTC Pink:…